Highbridge Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Highbridge Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-14,252	Closed	-$172K	–	1436
2014 Q2	$172K	Sell	14,252 -56,269	-80%	-$665K	﹤0.01%	983
2014 Q1	$822K	Buy	+70,521	New	+$1.19M	0.01%	600
2013 Q4	–	Sell	-16,976	Closed	-$244K	–	1416
2013 Q3	$244K	Buy	+16,976	New	+$260K	﹤0.01%	1114

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Highbridge Capital Management's MNTA Position: Q3 2014 in Review

Highbridge Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2014, closing a stake of 14,252 shares — an estimated $172K sold.

Highbridge Capital Management first reported a position in MNTA in Q3 2013 and held it in 3 quarters. The position peaked at $822K in Q1 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q3 2014.

Highbridge Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
Highbridge Capital Management sold 14,252 Momenta Pharmaceuticals, Inc. shares in Q3 2014, an estimated $172K.
Highbridge Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 3 quarters.
Highbridge Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $822K in Q1 2014.
143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2014.

Based on Highbridge Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.